Henkel announced the acquisition of Molecule Corp., a privately owned, technology-driven enterprise focused on product innovation in additive manufacturing.
Molecule Corp. provides solutions for 3D printing applications including medical device, aerospace, automotive and a variety of consumer goods – as well as industrial inkjet materials. The US-based company is headquartered in Concord (CA), in the San Francisco Bay Area.
“Molecule Corp. and Henkel are an excellent fit,” says Philipp Loosen, Head of 3D Printing at Henkel. “Molecule’s strong 3D printing and inkjet resin technologies and digital development capabilities complement and strengthen our materials portfolio and build on our approach to offer a comprehensive range of customized additive manufacturing solutions.”
The acquisition is in line with Henkel’s strategy to strengthen its portfolio through targeted acquisitions. It is complementing and strengthening Henkel’s technology portfolio for durable and functional parts in additive manufacturing (3D printing). It also enhances Henkel’s capacities to invent and develop new material or material components and grants access to industrial inkjet applications.
Both parties agreed to not disclose any financial details of the transaction.
Filed Under: 3D printing • additive manufacturing • stereolithography